Incidence of Rifampicin Resistance in Periprosthetic Joint Infection: A Single-Centre Cohort Study on 238 Patients
Background. Rifampicin is a pillar in the treatment of periprosthetic joint infection (PJI). However, rifampicin resistance is an increasing threat to PJI treatment. This study explores the incidence of rifampicin-resistant bacteria over time in a Swedish tertiary referral centre and the association...
Main Authors: | Stergios Lazarinis, Nils P. Hailer, Josef D. Järhult, Anders Brüggemann |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-09-01
|
Series: | Antibiotics |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-6382/12/10/1499 |
Similar Items
-
Early Staphylococcal Periprosthetic Joint Infection (PJI) Treated with Debridement, Antibiotics, and Implant Retention (DAIR): Inferior Outcomes in Patients with Staphylococci Resistant to Rifampicin
by: Hannah K. Eriksson, et al.
Published: (2023-11-01) -
Incidence of periprosthetic joint infection after primary total hip arthroplasty is underestimated: a synthesis of meta-analysis and bibliometric analysis
by: Zi-Jun Zeng, et al.
Published: (2023-08-01) -
Periprosthetic joint infection:A South African perspective
by: J S Hiddema
Published: (2023-06-01) -
Activated mast cells in periprosthetic joint infection-associated tissue
by: Cody R. Fisher, et al.
Published: (2023-08-01) -
Temporal trends in revision rate due to knee periprosthetic joint infection: a study of 115,120 cases from the Danish Knee Arthroplasty Register
by: Marie Anneberg, et al.
Published: (2023-12-01)